“On November 2, 2021, the CDC’s Advisory Committee on Immunization Practices [ACIP] unanimously voted to recommend the Pfizer EUA COVID shot for children ages 5-11 years. As has been documented, ACIP is rife with conflicts of interest and ties to the biopharmaceutical complex. Money, careers, status, influence. While that initial vote to recommend an experimental and untested injectable product was blatantly unscientific, under the cover of ‘crisis’, it served another purpose: to ‘soften the ground’ for what would come.
On October 20, 2022, ACIP again unanimously voted to recommend the unlicensed EUA COVID shots for young children, green-lighting the injectable products to be added to The Schedule. This vote accepted either Pfizer or Moderna products for an even younger age group than before: infants, as young as 6 months old.
Prior to COVID, no Emergency Use Authorized product had ever been added to The Schedule before. This is a big deal, but both the public health agencies and their captured press brigade underplayed the importance. In lockstep (the very same day), Pfizer announced a 400% price increase on their COVID jab. As with all of the shots on The Schedule, listing is a veritable guarantee for elephantine long-term profit.”